
Writer
Anand Sathappan
BPharm
Anand Sathappan is a pharmacy graduate with interests in pharmaceutical sciences, pharmacology, and medical writing. He also holds certification in medical coding and has familiarity with pharmacology and healthcare documentation. His work focuses on exploring developments in pharmaceuticals and presenting scientific information in a clear and structured manner.
18
Articles written or reviewed
About Anand
Anand Sathappan (BPharm) is a writer at Pharmacally, with 18 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Anand Sathappan
Clinical TrialsOcugen’s OCU410 Demonstrates 31% Lesion Reduction in Phase 2 GA Trial
GenericsViatris’ Effexor SR Becomes First Approved Treatment for Generalized Anxiety Disorder in Japan
Clinical TrialsPfizer and Valneva Report >70% Efficacy for Lyme Vaccine Candidate in Phase 3 Study
Clinical TrialsChugai Files in Japan for Ocular Implant Component of Ranibizumab Port Delivery Platform
New Drug ApprovalWegovy HD Approved by FDA After Trials Show ~21% Weight Loss
Drugs Safety AlertEisai Pulls Tazverik in Japan After Global Safety Review
Mergers & AcquisitionsSandoz Bets on $320B Biosimilar Opportunity with New Samsung Bioepis Partnership
Clinical TrialsNRx Targets FDA Approval for NRX-100 in Severe Depression
LifestyleMouth Taping for Better Sleep: Does Sleeping with Tape on Your Mouth Actually Work?Our people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala